SEARCH

SEARCH BY CITATION

References

  • ALBIN, R.L., YOUNG, A.B. & PENNEY, J.B. (1989). The functional anatomy of basal ganglia disorders. Trends Neurosci., 12, 366375.
  • BEAUMONT, V. & ZUCKER, R.S. (2000). Enhancement of synaptic transmission by cyclic AMP modulation of presynaptic Ih channels. Nat. Neurosci., 3, 133141.
  • CAPOGNA, M., GAHWILER, B.H. & THOMPSON, S.M. (1995). Presynaptic enhancement of inhibitory synaptic transmission by protein kinases A and C in the rat hippocampus in vitro. J. Neurosci., 15, 12491260.
  • CHERGUI, K., BOURON, A., NORMAND, E. & MULLE, C. (2000). Functional GluR6 kainate receptors in the striatum: Indirect downregulation of synaptic transmission. J. Neurosci., 20, 21752182.
  • CHESSELET, M.F. & DELFS, J.M. (1996). Basal ganglia and movement disorders: an update. Trends Neurosci., 19, 417422.
  • CHIJIWA, T., MISHIMA, A., HAGIWARA, M., SANO, M., HAYASHI, K., INOUE, T., NAITO, K., TOSHIOKA, T. & HIDAKA, H. (1990). Inhibition of forskolin-induced neurite outgrowth and protein phosphorylation by a newly synthesized selective inhibitor of cyclic AMP-dependent protein kinase, N-[2-(p-bromocinnamylamino)ethyl]-5-isoquinolinesulfonamide (H-89), of PC12D pheochromocytoma cells. J. Biol. Chem., 265, 52675272.
  • DELONG, M.R. (1990). Primate models of movement disorders of basal ganglia origin. Trends Neurosci., 13, 281285.
  • GRONDIN, R., BEDARD, P.J., HADJ TAHAR, A., GREGOIRE, L., MORI, A. & KASE, H. (1999). Antiparkinsonian effect of a new selective adenosine A2A receptor antagonist in MPTP-treated monkeys. Neurology, 52, 16731677.
  • GUBITZ, A.K., WIDDOWSON, L., KUROKAWA, M., KIRKPATRICK, K.A. & RICHARDSON, P.J. (1996). Dual signalling by the adenosine A2a receptor involves activation of both N- and P-type calcium channels by different G proteins and protein kinases in the same striatal nerve terminals. J. Neurochem., 67, 374381.
  • KANDA, T., JACKSON, M.J., SMITH, L.A., PEARCE, R.K., NAKAMURA, J., KASE, H., KUWANA, Y. & JENNER, P. (1998). Adenosine A2A antagonist: a novel antiparkinsonian agent that does not provoke dyskinesia in parkinsonian monkeys. Ann. Neurol., 43, 507513.
  • KANDA, T., SHIOZAKI, S., SHIMADA, J., SUZUKI, F. & NAKAMURA, J. (1994). KF17837: a novel selective adenosine A2A receptor antagonist with anticataleptic activity. Eur. J. Pharmacol., 256, 263268.
  • KASE, H. (2001). New aspects of physiological and pathophysiological functions of adenosine A2A receptor in basal ganglia. Biosci. Biotechnol. Biochem., 65, 14471457.
  • KIRK, I.P. & RICHARDSON, P.J. (1994). Adenosine A2a receptor-mediated modulation of striatal [3H]GABA and [3H]acetylcholine release. J. Neurochem., 62, 960966.
  • KONDO, S. & MARTY, A. (1997). Protein kinase A-mediated enhancement of miniature IPSC frequency by noradrenaline in rat cerebellar stellate cells. J. Physiol. (Lond.), 498, 165176.
  • KUROKAWA, M., KIRK, I.P., KIRKPATRICK, K.A., KASE, H. & RICHARDSON, P.J. (1994). Inhibition by KF17837 of adenosine A2A receptor-mediated modulation of striatal GABA and ACh release. Br. J. Pharmacol., 113, 4348.
  • LLANO, I. & GERSCHENFELD, H.M. (1993). Beta-adrenergic enhancement of inhibitory synaptic activity in rat cerebellar stellate and Purkinje cells. J. Physiol. (Lond.), 468, 201224.
  • MADISON, D.V. & NICOLL, R.A. (1986). Cyclic adenosine 3′,5′-monophosphate mediates beta-receptor actions of noradrenaline in rat hippocampal pyramidal cells. J. Physiol. (Lond.), 372, 245259.
  • MAYFIELD, R.D., SUZUKI, F. & ZAHNISER, N.R. (1993). Adenosine A2a receptor modulation of electrically evoked endogenous GABA release from slices of rat globus pallidus. J. Neurochem., 60, 23342337.
  • MORI, A., SHINDOU, T., ICHIMURA, M., NONAKA, H. & KASE, H. (1996). The role of adenosine A2a receptors in regulating GABAergic synaptic transmission in striatal medium spiny neurons. J. Neurosci., 16, 605611.
  • NONAKA, H., ICHIMURA, M., TAKEDA, M., NONAKA, Y., SHIMADA, J., SUZUKI, F., YAMAGUCHI, K. & KASE, H. (1994a). KF17837 ((E)-8-(3,4-dimethoxystyryl)1,3-dipropyl-7-methylxanthine), a potent and selective adenosine A2 receptor antagonist. Eur. J. Pharmacol., 267, 335341.
  • NONAKA, H., MORI, A., ICHIMURA, M., SHINDOU, T., YANAGAWA, K., SHIMADA, J. & KASE, H. (1994b). Binding of [3H]KF17837S, a selective adenosine A2 receptor antagonist, to rat brain membranes. Mol. Pharmacol., 46, 817822.
  • OCHI, M., KOGA, K., KUROKAWA, M., KASE, H., NAKAMURA, J. & KUWANA, Y. (2000). Systemic administration of adenosine A2A receptor antagonist reverses increased GABA release in the globus pallidus of unilateral 6-hydroxydopamine-lesioned rats: a microdialysis study. Neuroscience, 100, 5362.
  • OZAKI, N., SHIBASAKI, T., KASHIMA, Y., MIKI, T., TAKAHASHI, K., UENO, H., SUNAGA, Y., YANO, H., MATSUURA, Y., IWANAGA, T., TAKAI, Y. & SEINO, S. (2000). Cyclic AMP-GEFII is a direct target of cyclic AMP in regulated exocytosis. Nat. Cell Biol., 2, 805811.
  • PARENT, A. & HAZRATI, L.N. (1995). Functional anatomy of the basal ganglia. II. The place of subthalamic nucleus and external pallidum in basal ganglia circuitry. Brain Res. Brain Res. Rev., 20, 128154.
  • RADNIKOW, G. & MISGELD, U. (1998). Dopamine D1 receptors facilitate GABAA synaptic currents in the rat substantia nigra pars reticulata. J. Neurosci., 18, 20092016.
  • RICHARDSON, P.J., KASE, H. & JENNER, P.G. (1997). Adenosine A2A receptor antagonists as new agents for the treatment of Parkinson's disease. Trends Pharmacol. Sci., 18, 338344.
  • SAKABA, T. & NEHER, E. (2001). Preferential potentiation of fast-releasing synaptic vesicles by cyclic AMP at the calyx of Held. Proc. Natl. Acad. Sci. U.S.A., 98, 331336.
  • SCIANCALEPORE, M., STRATTA, F., FISHER, N.D. & CHERUBINI, E. (1995). Activation of metabotropic glutamate receptors increase the frequency of spontaneous GABAergic currents through protein kinase A in neonatal rat hippocampal neurons. J. Neurophysiol., 74, 11181122.
  • SHIMADA, J., KOIKE, N., NONAKA, H., SHIOZAKI, S., YANAGAWA, K., KANDA, T., KOBAYASHI, H., ICHIMURA, M., NAKAMURA, J., KASE, H. & SUZUKI, F. (1997). Adenosine A2A antagonists with potent anti-cataleptic activity. Bioorg. Med. Chem. Lett., 7, 23492352.
  • SHINDOU, T., MORI, A., KASE, H. & ICHIMURA, M. (2001). Adenosine A2A receptor enhances GABAA-mediated IPSCs in the rat globus pallidus. J. Physiol. (Lond.), 532, 423434.
  • SMITH, Y., BEVAN, M.D., SHINK, E. & BOLAM, J.P. (1998). Microcircuitry of the direct and indirect pathways of the basal ganglia. Neuroscience, 86, 353387.
  • SMITH, Y., WICHMANN, T. & DELONG, M.R. (1993). New ideas and data on structure and function. In The Basal Ganglia IV ed. Percheron, G., McKenzie, J.S. & Feger, J. pp. 5163. New York: Plenum Press.
  • TRUDEAU, L.-E., EMERY, D.G. & HAYDON, P.G. (1996). Direct modulation of the secretory machinery underlies PKA-dependent synaptic facilitation in hippocampal neurons. Neuron, 17, 789797.
  • VAN CALKER, D., MULLER, M. & HAMPRECHT, B. (1979). Adenosine regulates via two different types of receptors, the accumulation of cyclic AMP in cultured brain cells. J. Neurochem., 33, 9991005.
  • WANG, H.L., LI, A. & WU, T. (1997). Vasoactive intestinal polypeptide enhances the GABAergic synaptic transmission in cultured hippocampal neurons. Brain Res., 746, 294300.